These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30226266)

  • 1. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
    Mondal S; Roy D; Sarkar Bhattacharya S; Jin L; Jung D; Zhang S; Kalogera E; Staub J; Wang Y; Xuyang W; Khurana A; Chien J; Telang S; Chesney J; Tapolsky G; Petras D; Shridhar V
    Int J Cancer; 2019 Jan; 144(1):178-189. PubMed ID: 30226266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
    Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
    Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
    Ray U; Roy D; Jin L; Thirusangu P; Staub J; Xiao Y; Kalogera E; Wahner Hendrickson AE; Cullen GD; Goergen K; Oberg AL; Shridhar V
    J Exp Clin Cancer Res; 2021 Jun; 40(1):182. PubMed ID: 34082797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses.
    Sarkar Bhattacharya S; Thirusangu P; Jin L; Roy D; Jung D; Xiao Y; Staub J; Roy B; Molina JR; Shridhar V
    Cell Death Dis; 2019 Sep; 10(10):725. PubMed ID: 31562297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth.
    Khurana A; Roy D; Kalogera E; Mondal S; Wen X; He X; Dowdy S; Shridhar V
    Oncotarget; 2015 Nov; 6(34):36354-69. PubMed ID: 26497553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.
    Roy D; Mondal S; Khurana A; Jung DB; Hoffmann R; He X; Kalogera E; Dierks T; Hammond E; Dredge K; Shridhar V
    Sci Rep; 2017 Feb; 7():41977. PubMed ID: 28169314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
    Chen Y; Johnson JD; Jayamohan S; He Y; Venkata PP; Jamwal D; Alejo S; Zou Y; Lai Z; Viswanadhapalli S; Vadlamudi RK; Kost E; Sareddy GR
    Mol Carcinog; 2024 Oct; 63(10):2026-2039. PubMed ID: 38990091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
    Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of the kinetics of hyperactivated ERK1/2-mediated autophagy during acquirement of chemoresistance.
    Bishnu A; Phadte P; Dhadve A; Sakpal A; Rekhi B; Ray P
    Cell Death Dis; 2021 Feb; 12(2):161. PubMed ID: 33558461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
    Zhang J; Xue W; Xu K; Yi L; Guo Y; Xie T; Tong H; Zhou B; Wang S; Li Q; Liu H; Chen X; Fang J; Zhang W
    Theranostics; 2020; 10(16):7245-7259. PubMed ID: 32641990
    [No Abstract]   [Full Text] [Related]  

  • 15. Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.
    Yang X; Shen J; Gao Y; Feng Y; Guan Y; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Int J Cancer; 2015 Oct; 137(8):2029-39. PubMed ID: 25904021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
    Sarkar Bhattacharya S; Thirusangu P; Jin L; Staub J; Shridhar V; Molina JR
    Br J Cancer; 2022 Oct; 127(7):1352-1364. PubMed ID: 35794237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production.
    Ge X; Cao Z; Gu Y; Wang F; Li J; Han M; Xia W; Yu Z; Lyu P
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):119-25. PubMed ID: 27262815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.
    Yang X; Feng Y; Gao Y; Shen J; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Gynecol Oncol; 2015 Apr; 137(1):134-42. PubMed ID: 25677062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
    Kreitzburg KM; Fehling SC; Landen CN; Gamblin TL; Vance RB; Arend RC; Katre AA; Oliver PG; van Waardenburg RCAM; Alvarez RD; Yoon KJ
    Cancer Lett; 2018 Nov; 436():75-86. PubMed ID: 30120964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
    Liu X; Zhao Y; Zhang E; Yan H; Lv N; Cai Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):332-338. PubMed ID: 31153642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.